SATT AxLR transfers a skin biological age assessment technology to Skinomix.ai
Skinomix Team
May 21, 2026
Skinomix.ai announces an exclusive licensing agreement with SATT AxLR for a patented technology resulting from the work of Prof. Jean-Marc Lemaitre at IRMB (INSERM/CHU de Montpellier/Université de Montpellier). The innovation is based on a protein clock designed to estimate the biological age of skin from markers found in the stratum corneum.
This non-invasive approach helps make skin aging measurable and track changes driven by skincare products or dermocosmetic protocols. It supports Skinomix.ai's ambition to provide brands and dermatologists with robust biological indicators for personalization and innovation.
Beyond dermocosmetics, the press release also highlights the technology's potential contribution to longevity, through the identification of healthspan biomarkers that could support a broader approach to healthy aging.